Roth Capital analyst Suji Desilva raised the firm’s price target on MaxLinear (MXL) to $18 from $11 and keeps a Neutral rating on the shares. The company reported and guided revenue ahead of consensus, reflecting recovery and growth driver benefits in core segments. Roth also believes MaxLinear remains on track for strong optical growth this year, and is encouraged by an expected return to operating profitability this quarter, reflecting recent cost restructuring efforts.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MXL: